Thibeault; Carl

Patent Applications and Registrations

Patent applications and USPTO patent grants for Thibeault; Carl.The latest application filed is for "inhibitors of cytomegalovirus".

Company Profile

0.15.16

Thibeault; Carl - Mascouche CA
THIBEAULT; Carl - US
Thibeault; Carl - Mascouch CA
Thibeault; Carl - Laval CA
Thibeault; Carl - Quebec CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
7-hydroxy-indolinyl antagonists of P2Y.sub.1 receptor Grant 9,540,323 - L'Heureux , et al. January 10, 2	2017-01-10
Inhibitors of cytomegalovirus Grant 9,505,775 - Thibeault , et al. November 29, 2	2016-11-29
7-hydroxy-spiropipiperidine indolinyl antagonists of P2Y.sub.1 receptor Grant 9,428,504 - Thibeault , et al. August 30, 2	2016-08-30
Inhibitors of cytomegalovirus Grant 9,334,249 - Fader , et al. May 10, 2	2016-05-10
Cytomegalovirus inhibitor compounds Grant 9,315,499 - Fader , et al. April 19, 2	2016-04-19
Inhibitors of cytomegalovirus Grant 9,284,310 - Fader , et al. March 15, 2	2016-03-15
Inhibitors Of Cytomegalovirus App 20150315180 - FADER; Lee ; et al.	2015-11-05
Inhibitors Of Cytomegalovirus App 20150284348 - Fader; Lee ; et al.	2015-10-08
Inhibitors Of Cytomegalovirus App 20150274744 - Thibeault; Carl ; et al.	2015-10-01
7-hydroxy-indolinyl Antagonists Of P2y1 Receptor App 20150259286 - L'Heureux; Alexandre ; et al.	2015-09-17
Amino-heteroaryl 7-hydroxy-spiropiperidine indolinyl antagonists of P2Y1 receptor Grant 9,120,798 - Qiao , et al. September 1, 2	2015-09-01
Amino-heteroaryl 7-hydroxy-spiropiperidine Indolinyl Antagonists Of P2y1 Receptor App 20150197521 - Qiao; Jennifer X. ; et al.	2015-07-16
7-hydroxy-spiropipiperidine Indolinyl Antagonists Of P2y1 Receptor App 20150166538 - Thibeault; Carl ; et al.	2015-06-18
Cytomegalovirus Inhibitor Compounds App 20150158861 - Fader; Lee ; et al.	2015-06-11
Inhibitors of human immunodeficiency virus replication Grant 8,841,331 - Yoakim , et al. September 23, 2	2014-09-23
Process For The Preparation Of An Hiv Integrase Inhibitor App 20140094609 - Brown; Brandon H. ; et al.	2014-04-03
Inhibitors Of Human Immunodeficiency Virus Replication App 20130203747 - Yoakim; Christiane ; et al.	2013-08-08
Inhibitors of human immunodeficiency virus replication Grant 8,338,441 - Yoakim , et al. December 25, 2	2012-12-25
Heteroaryl compounds as P2Y.sub.1 receptor inhibitors Grant 8,273,772 - Sutton , et al. September 25, 2	2012-09-25
Inhibitors Of Human Immunodeficiency Virus Replication App 20100292227 - YOAKIM; CHRISTIANE ; et al.	2010-11-18
C-linked cyclic antagonists of P2Y.sub.1 receptor useful in the treatment of thrombotic conditions Grant 7,700,620 - Sutton , et al. April 20, 2	2010-04-20
Heteroaryl Compounds As P2y1 Receptor Inhibitors App 20100093689 - Sutton; James C. ; et al.	2010-04-15
Urea antagonists of P2Y.sub.1receptor useful in the treatment of thrombotic conditions Grant 7,674,828 - Chao , et al. March 9, 2	2010-03-09
Urea Antagonists Of P2y1 Receptor Useful In The Treatment Of Thrombotic Conditions App 20080280905 - Chao; Hannguang J. ; et al.	2008-11-13
Urea antagonists of P2Y.sub.1 receptor useful in the treatment of thrombotic conditions Grant 7,388,021 - Chao , et al. June 17, 2	2008-06-17
C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions App 20060293336 - Sutton; James C. ; et al.	2006-12-28
Heteroaryl compounds as P2Y1 receptor inhibitors App 20060173002 - Sutton; James C. ; et al.	2006-08-03
Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions App 20050267119 - Chao, Hannguang J. ; et al.	2005-12-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.